Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma.
about
Logic Learning Machine and standard supervised methods for Hodgkin's lymphoma prognosis using gene expression data and clinical variables.Macrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphomaCSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma.Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trialCancer immunotherapy: Strategies for personalization and combinatorial approaches.CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.Clinical significance of macrophage heterogeneity in human malignant tumors.Role of tumor-associated macrophages in hematological malignancies.Prognostic Biomarkers for Hodgkin Lymphoma.Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children.Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages.Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets.Tumor-associated macrophages as a prognostic parameter in multiple myeloma.Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-γ expression in the neoplastic cells and macrophages of Hodgkin lymphoma: clinicopathologic correlations and potential prognostic implications.CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment.Essential genes of the macrophage response to Staphylococcus aureus exposure.Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study
P2860
Q31111207-D084FC61-0EFD-420C-910F-591174704FE1Q34627838-3D17F523-92E8-491A-AF93-0800CDE80D2EQ35661295-88A63832-52A7-4DD6-8237-C5927087F3DBQ36164491-C68CCF94-73F2-4D62-90FE-480701C0A001Q36333526-B84D06F7-ADDE-4876-879D-E7F2D929FD39Q36387028-57CE870F-D76F-4124-B4B1-91238574CB37Q36706850-686BA58D-C99C-488C-ADB9-C8945846DF19Q37529430-D6D884CB-5CB6-4FB3-A3E4-5433330D4C2CQ38156195-FACB15F7-7779-4927-A0E2-8AA1E400733CQ38364405-071F5C6F-4942-4FAC-8B6B-A2052427766AQ38588503-749B1729-681A-4E13-9192-848DC51639FCQ38882112-6E472846-A001-415D-816C-315B6F651F2FQ40912853-8C4C9FCD-9B75-4744-99FD-09ED4F6F277CQ45231156-147ABE1C-42D9-4D09-B56F-DEF670A10716Q47437693-838727BB-4E00-4DA2-987B-3E4030B0D54FQ48890938-05C183E7-F132-4C36-A585-BDFDFFEBB7FDQ49592738-06C42FF8-17F0-4B91-A798-DA4B9F0A13BEQ50878568-0667845F-1DA6-4D08-B7DF-3F39FFD5FB62Q50964992-94447779-D71E-4D4B-BA6F-D4F3007CA952Q53068100-722CA313-0037-4C19-96CB-0F98BC07D9FEQ55019731-9F2BECC2-6432-497C-A291-468C6A4BCEA6Q57917353-366F96E9-1A7A-4BED-A843-885FCFA56E9D
P2860
Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immunohistochemical markers fo ...... classical Hodgkin's lymphoma.
@ast
Immunohistochemical markers fo ...... classical Hodgkin's lymphoma.
@en
type
label
Immunohistochemical markers fo ...... classical Hodgkin's lymphoma.
@ast
Immunohistochemical markers fo ...... classical Hodgkin's lymphoma.
@en
prefLabel
Immunohistochemical markers fo ...... classical Hodgkin's lymphoma.
@ast
Immunohistochemical markers fo ...... classical Hodgkin's lymphoma.
@en
P2093
P2860
P1433
P1476
Immunohistochemical markers fo ...... classical Hodgkin's lymphoma.
@en
P2093
Ana M Martin-Moreno
Anas Younes
Beatriz Sánchez-Espiridión
Carlos Montalbán
Juan F Garcia
L Jeffrey Medeiros
P2860
P304
P356
10.3324/HAEMATOL.2011.055459
P577
2012-02-07T00:00:00Z